Related Experiment Video
Updated: Aug 8, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Bridging the gap: The critical role of laboratory developed tests in clinical toxicology
Jaime H Noguez1,2, Christopher D Koch3,4
1Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Abstract:
•Toxicology testing provides valuable information for patient management.•Current in vitro diagnostics (IVDs) are unable to meet all clinical needs.•Lab-developed tests (LDTs) in toxicology can be used to close clinical care gaps.•LDTs in clinical toxicology are almost exclusively mass spectrometry-based methods.
Related Concept Videos
Preclinical Development: Overview
Clinical Trials: Overview
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Mutagenicity and Carcinogenicity

